Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Lilly cuts price of Zepbound; leaked memo on child deaths due to Covid vaccines triggers reaction from former FDA chiefs

In Phispers this week, Eli Lilly reduced prices of its obesity drug Zepbound sold through LillyDirect, aiming to expand access...

Impressions : 835

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

In Phispers this week, Eli Lilly became the first pharmaceutical company to reach a market valuation of US$ 1 trillion, driven ...

Impressions : 1320

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

In this week’s Phispers, Merck struck a US$ 9.2 billion deal to acquire Cidara Therapeutics to strengthen its infectious-...

Impressions : 730

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

In Phispers this week, Pfizer won its high stakes battle with Novo Nordisk for the obesity-focused biotech Metsera. The deal i...

Impressions : 1024

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly cuts price of Zepbound; leaked memo on child deaths due to Covid vaccines triggers reaction from former FDA chiefs

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

MSN's Generics Brivaracetam Receives Tentative Approval in US

Mankind's Generics Sugammadex Receives Tentative Approval in US

Amneal's Generics Albuterol Sulfate Receives Approval in US

Otsuka Pharm's Biologics Voyxact Receives Approval in US

Zydus' Generics Verapamil HCl Receives Approval in US

Alembic Pharms' Generics Dapagliflozin Receives Approval in US

Micro's Generics Olmesartan Medoxomil Receives Approval in US

Apotex's Ruxolitinib Receives Approval in US

Inventia Hlthcare Generics Dapagliflozin Receives Approval in US

Alvotech USA's Ustekinumab Receives BLA Approval in US

Ningxia Taiyicin Biotech's Fails EDQM inspection

Rhyz Analytical's Receives FDA Warning Letter

Turbare Manufacturing's Receives FDA Warning Letter

FDA Issues Form 483 to North American Custom Laboratories

Wells Pharma of Houston's Receives FDA Warning Letter

Owen Bio's Receives FDA Warning Letter

FDA Issues Form 483 to Fareva Amboise

FDA Issues Form 483 to Immacule Lifesciences

Cdymax Pharma's Receives FDA Warning Letter

Siddha Flower Essences' Receives FDA Warning Letter

Slimmer price tag helps Wegovy sales gain weight

Respiratory drug sales peak in November amid worsening AQI

OSE Immuno Announces Strategic Amendment to AbbVie

Lilly declares first-quarter 2026 dividend

Jim Lang Elected to Halozyme's Board of Directors

Hikma launches TYZAVAN (vancomycin injection, USP) in the US

GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya

Dr Reddy's inks licensing deal to sell Immutep's cancer drug

Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia

A New Era in Parkinson's: Solengepras Shifts Beyond Dopamine

Hikma launches TYZAVAN (vancomycin injection, USP) in the US

Lupin Receives Tentative U.S. FDA Approval For Siponimod Tablets

AT&T Sues Generic Drugmakers Over Alleged Price-Fixing Scheme

Amneal Gets FDA Nod For Albuterol Sulfate Inhaler

NRx Pharmaceuticals Announces Fda Receipt of ANDA for Ketafree

Nexus Pharmaceuticals Launches Tacrolimus Injection

Amneal Gets FDA Nod For Cyclosporine Ophthalmic Emulsion 0.05%

Zydus Gets Tentative FDA Nod For Empagliflozin, Linagliptin

Zentiva Earns ESG Transparency Award 2025

Generic HIV Drug Rollout To Take A Hit On Trial Push

OSE Immuno Announces Strategic Amendment to AbbVie

Immix Biopharma Reports Positive Phase 2 NXC-201 Data at ASH 2025

Biocon To Merge Biocon Biologics In $5.5 Billion Deal

Takeda Seals $1.2 Billion Oncology Deal With Innovent Biologics

Wave, Structure stocks double on obesity data readouts

Protara Announces Closing of $75 Million Public Offering

Moleculin Announces New Annamycin Collaboration in Brain Tumors

Lilly looks to become innovation 'backbone,' exec says

Kymera Therapeutics Announces Proposed Public Offering

ASH: Regeneron eyes simpler regimens to grow bispecifics' reach

Is biopharma facing a microbial manufacturing crunch?

DCC Backs Separate Licensing for Bulk Drugs and Excipients

Pharma Gains from Rupee's Fall Despite Reliance on APIs

Promoting Indigenous Pharma Manufacturing

Mangalam Drugs Receives Rs. 15 Crore Repeat Export Order

DoP Seeks Applications For PLI Scheme To Produce 2 Bulk Drugs

Moehs visits the UPF

Dipharma Introduces Method To Detect Nitrosamine formation APIs

Supriya Lifescience Expands Lote Facility With New Module E

HRV Pharma And Metrochem Forge Strategic CDMO Alliance

FDA Panel Votes Against J&J Shunt Implant For Heart Failure

USFDA Issues Form 483 With 3 Observations To Ipca's Tarapur Plant

Precipio Identifies Unauthorized Access to Isolated Storage

FDA Official: CDER Warning Letters Up 50% In FY 2025

DOJ, FDA Prosecutions Highlight HCG Sales Risks

Bihar IPA Criticizes Regulatory Failure As DEG Syrup Kills 23

FDA Letter To Daiichi Takes Aim At Turalio Patient Video

Indonesia Firm Executive Suspect in Radioactive Contamination

Ethiopian Team Visits Telangana for Drug Regulation Study

Torrent Pharma Fined Rs 41 Crore Over Alleged Wrong GST Refund

A New Era in Parkinson's: Solengepras Shifts Beyond Dopamine

Groundbreaking study identifies 250 genes driving ME & long COVID

FDA clears Resmed AI for personalizing CPAP settings